The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy: ErratumMedicine: October 2016 - Volume 95 - Issue 42 - p e18ea doi: 10.1097/01.md.0000505546.85718.ea Erratum Author Information Article Outline This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 Reference In the article “The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy”,[1] which appeared in Volume 95, Issue 33 of Medicine, some affiliation information was originally given incorrectly. The article has since been corrected online. Back to Top | Article Outline Reference1. Tai H, Wang M-Y, Zhao Y-P, et al.. The effect of alogliptin on pulmonary function in obese patients with type 2 diabetes inadequately controlled by metformin monotherapy. Medicine. 2016 95:e4541. Cited Here... | View Full Text | PubMed | CrossRef Copyright © 2016 The Authors. Published by Wolters Kluwer Health, Inc. All rights reserved.
